Neuropeptide y expression in cutaneous melanoma

Journal of the American Academy of Dermatology

Volumn 66, Issue 6, 2012, Pages

  Gilaberte, Yolanda ^a,b   Roca, M Jose ^a   Garcia Prats, M Dolores ^a   Coscojuela, Carmen ^a   Arbues, M Dolores ^a   Vera Alvarez, Jesús J ^a  

^a HOSPITAL SAN JORGE   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

Author keywords

melanocyte stimulating hormone; immunochemistry; melanocytic nevus; melanoma; melanoma invasiveness; melanoma metastasis; neuropeptide Y

Indexed keywords

ALPHA INTERMEDIN; NEUROPEPTIDE Y;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CORRELATION ANALYSIS; CUTANEOUS MELANOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT LENTIGO; MELANOCYTIC NEVUS; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPAIN;

AGED; ALPHA-MSH; FEMALE; HORMONES; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MELANOMA; MIDDLE AGED; MITOTIC INDEX; NEOPLASM INVASIVENESS; NEUROPEPTIDE Y; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 84861230516     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.02.015     Document Type: Article

References (38)

1. A. Slominski Neuroendocrine activity of the melanocyte Exp Dermatol 18 2009 760 763
2. M. Martinez-Alonso, N. Llecha, M. Mayorga, A. Sorolla, X. Dolcet, and V. Sanmartin Expression of somatostatin receptors in human melanoma cell lines: effect of two different somatostatin analogues, octreotide and SOM230, on cell proliferation J Int Med Res 37 2009 1813 1822
3. M. Muñoz, M. Rosso, M. Robles-Frias, M. Salinas-Martín, R. Rosso, and A. González-Ortega The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines Lab Invest 90 2010 1259 1269
4. Y. Gilaberte, J. Vera, C. Coscojuela, M. Roca, C. Parrado, and S. González Expression of galanin in melanocytic tumors [in Spanish] Actas Dermo-Sif 98 2007 24 34
5. G. Schwartze, and H. Fiedler The diagnostic significance of alpha-MSH in malignant melanoma of man [in German] Hautarzt 45 1994 468 470
6. P. Eves, S. MacNeil, and J. Haycock alpha-Melanocyte stimulating hormone, inflammation and human melanoma Peptides 27 2006 444 452
7. H. Lee, B. Wall, and S. Chen G-protein-coupled receptors and melanoma Pigment Cell Melanoma Res 21 2008 415 428
8. K. Tatemoto Neuropeptide Y: complete amino acid sequence of the brain peptide Proc Natl Acad Sci U S A 79 1982 5485 5489
9. T. Pedrazzini, F. Pralong, E. Grouzmann, and Y. Neuropeptide the universal soldier Cell Mol Life Sci 60 2003 350 377
10. E. Benarroch Neuropeptide Y: its multiple effects in the CNS and potential clinical significance Neurology 72 2009 1016 1020
11. E. Peters, M. Ericson, J. Hosoi, K. Seiffert, M. Hordinsky, and J. Ansel Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance J Invest Dermatol 126 2006 1937 1947
12. M. Körner, and J. Reubi NPY receptors in human cancer: a review of current knowledge Peptides 28 2007 419 425
13. J. Kitlinska, K. Abe, L. Kuo, J. Pons, M. Yu, and L. Li Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors Cancer Res 65 2005 1719 1728
14. J. Reubi, M. Gugger, B. Waser, and J. Schaer Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets Cancer Res 61 2001 4636 4641
15. M. Körner, B. Waser, and J. Reubi Neuropeptide Y receptor expression in human primary ovarian neoplasms Lab Invest 84 2004 71 80
16. M. Körner, B. Waser, and J. Reubi Neuropeptide Y receptors in renal cell carcinomas and nephroblastomas Int J Cancer 115 2005 734 741
17. R.T. Millar, and C. Estran Heat-induced epitope retrieval with a pressure cooker Appl Immunohistochem 3 1995 190 193
18. C. Balch, J. Gershenwald, S. Soong, J. Thompson, M. Atkins, and D. Byrd Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 2009 6199 6206
19. S. Ugurel, J. Utikal, and J. Becker Tumor biomarkers in melanoma Cancer Control 16 2009 219 224
20. A. Piris, and M.J. Mihm Progress in melanoma histopathology and diagnosis Hematol Oncol Clin North Am 23 2009 467 480
21. E. Lee, D. Grant, S. Movafagh, and Z. Zukowska Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice Peptides 24 2003 99 106
22. M. Slater, R. Scolyer, A. Gidley-Baird, J. Thompson, and J. Barden Increased expression of apoptotic markers in melanoma Melanoma Res 13 2003 137 145
23. E. Margineanu, C. Cotrutz, and C. Cotrutz Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis Rev Med Chir Soc Med Nat Iasi 112 2008 432 436
24. J. Wheway, H. Herzog, and F. Mackay NPY and receptors in immune and inflammatory diseases Curr Top Med Chem 7 2007 1743 1752
25. D. Oble, R. Loewe, P. Yu, and M.J. Mihm Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma Cancer Immun 9 2009 3
26. A. Spatz, G. Batist, and A. Eggermont The biology behind prognostic factors of cutaneous melanoma Curr Opin Oncol 22 2010 163 168
27. P. Bjellerup, E. Theodorsson, H. Jörnvall, and P. Kogner Limited neuropeptide Y precursor processing in unfavorable metastatic neuroblastoma tumors Br J Cancer 83 2000 171 176
28. M. Nowicki, D. Ostalska-Nowicka, and B. Miskowiak Prognostic value of stage IV neuroblastoma metastatic immunophenotype in the bone marrow: preliminary report J Clin Pathol 59 2006 150 152
29. K. Rasiah, J. Kench, M. Gardiner-Garden, A. Biankin, D. Golovsky, and P. Brenner Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis Cancer Epidemiol Biomarkers Prev 15 2006 711 716
30. M. Ruscica, E. Dozio, S. Boghossian, G. Bovo, V. Martos Riaño, and M. Motta Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells Endocrinology 147 2006 1466 1473
31. A. Liu, B. Furusato, L. Ravindranath, Y. Chen, V. Srikantan, and D. McLeod Quantitative analysis of a panel of gene expression in prostate cancer-with emphasis on NPY expression analysis J Zhejiang Univ Sci B 8 2007 853 859
32. D. Skibola, M. Smith, P. Bracci, A. Hubbard, L. Agana, and S. Chi Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma Cancer Epidemiol Biomarkers Prev 14 2005 1251 1256
33. I. Knerr, S. Schuster, P. Nomikos, M. Buchfelder, J. Dötsch, and E. Schoof Gene expression of adrenomedullin, leptin, their receptors and neuropeptide Y in hormone-secreting and non-functioning pituitary adenomas, meningiomas and malignant intracranial tumors in humans Neuropathol Appl Neurobiol 27 2001 215 222
34. M. Ruscica, E. Dozio, M. Motta, and P. Magni Relevance of the neuropeptide Y system in the biology of cancer progression Curr Top Med Chem 7 2007 1682 1691
35. M. Körner, and J. Reubi Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors J Neuropathol Exp Neurol 67 2008 741 749
36. M. Körner, B. Waser, and J. Reubi High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia Clin Cancer Res 10 2004 8426 8433
37. C. Tu, D. Zhao, and X. Lin Levels of neuropeptide-Y in the plasma and skin tissue fluids of patients with vitiligo J Dermatol Sci 27 2001 178 182
38. M. Nagahama, Y. Funasaka, M. Fernandez-Frez, A. Ohashi, A. Chakraborty, and M. Ueda Immunoreactivity of alpha-melanocyte-stimulating hormone, adrenocorticotrophic hormone and beta-endorphin in cutaneous malignant melanoma and benign melanocytic nevi Br J Dermatol 138 1998 981 985